Antidepression drugs. Oxybutynin, an anticholinergic used to treat urinary incontinence, may provide breast cancer survivors with an alternative treatment option for hot flashes, according to new ...

What are the concerns related to using long-acting or extended-release anticholinergic agents over long time periods? Are other medications available that would better ameliorate urinary incontinence?

May 23, 2011 — Use of short- and long-acting inhaled anticholinergic medications (IACs) is associated with an increased risk for acute urinary retention (AUR) in men with chronic obstructive pulmonary ...

Due to its urinary symptoms that include nocturia, urgency, and frequency, this condition causes social embarrassment and a poor quality of life. Oxybutynin, also marketed as Ditropan XL, is an ...

IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Urovant Sciences (Nasdaq: UROV) today announced positive efficacy and safety data from the vibegron EMPOWUR long term extension study with patient ...

NEW YORK (Reuters Health) - The odds are high that a woman who is prescribed an "anticholinergic" drug to relieve urinary incontinence or other lower urinary tract symptom will discontinue the ...

Medications with anticholinergic properties have been consistently associated with a wide range of adverse outcomes for older adults including cognitive impairment, yet these drugs continue to be ...

This medication works by relaxing the muscles of the bladder. It helps to reduce bladder spasms, the urge to pass urine, and the frequency of urination. If you have not discussed this with your doctor ...

Higher cardiovascular morbidity was associated with more severe urge urinary incontinence and worse quality of life. Women at high cardiovascular (CV) risk may benefit less from anticholinergics, new ...

People who use drugs with anticholinergic effects, including certain antidepressants, drugs for urinary incontinence and common antihistamines, are at higher risk of developing cardiovascular disease.